-
As you can see from the figure below, the performance of the venture capital industry has been reasonably consistent for the past few years, with about exits being about 15 percent of investments made five years earlier.
FORBES: The Health of the Venture Capital Industry
-
Many schemes assume, on the basis of past performance, a return of 7.5-8%, a figure that is highly implausible given the current low yields. (By contrast, in 1981, when Treasury bonds were yielding 13.5%, pension funds assumed a future annual return of just 6%.) Such rosy assumptions allow schemes to stint on their contributions, building up huge future risks.
ECONOMIST: Buttonwood
-
Mike Taylor, author of the report, said they expected Crossrail to boost prices by an average of 20% - a figure derived from "wide-ranging research" research as well as the performance of other rail infrastructure projects both in the UK and abroad.
BBC: Crossrail to boost house prices 'by up to 25%'
-
Under PERFORMANCE is the figure for the number of pupils eligible to take the tests and, next to that, the proportion of those deemed to have special educational needs (SEN) - with or without formal statements.
BBC: NEWS | UK | Education | Guide to the primary school tables
-
Figure 1 illustrates the variation in three-year relative return performance of four value and growth strategies.
FORBES: Value Stocks are in the Eye of the Beholder
-
The sales growth figure was also flattered by a relatively soft performance in the autumn of 2011, against which the more recent sales figures have been compared.
BBC: Primark sales jump by a quarter
-
They should never be the sole criterion for picking a fund, but they should figure in along with risk, expenses, past performance and the suitability of the fund category to your needs.
FORBES: The hidden cost of trading
-
He's a marvelous figure, the product of flawless writing more about that later plus a brilliant performance that's no less subtle for being theatrical.
WSJ: Classic, Your Name Is 'Mud' | Mud | At Any Price | The Reluctant Fundamentlist | Pain & Gain | Film Reviews by Joe Morgenstern
-
If she can't figure out a way to improve her company's performance, she may find herself going the way of other unlucky CEOs--regardless of their gender.
FORBES: People
-
The inconvenient truth, as Al Lewis, a leading figure of the disease management movement, explains, is that far too often, we use faulty techniques to assess the performance of these programs, resulting in essentially cooked data that, well, nobody believes.
FORBES: My 2012 Digital Health Awards: Company, Person, Book Of The Year